LITO

Main information

  • Trade name:
  • LITO 300 mg film-coated tablet
  • Dosage:
  • 300 mg
  • Pharmaceutical form:
  • film-coated tablet
  • Prescription type:
  • Prescription only
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • LITO 300 mg film-coated tablet
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Lithium
  • Product summary:
  • Suitability for use in older adult patients Lithii carbonas Avoid using in older persons. Serotonergic. Risk of QT prolongation. Narrow therapeutic range. Monitor the drug and sodium concentration in plasma. Do not use in renal insufficiency. Significant adverse effects include tremor, nausea, diarrhea, muscular weakness, ataxia och disturbances in thyroid and parathyroid function. Take interactions into account, especially with anti-inflammatory analgesics, ACE-inhibitors and diuretics.

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 7282
  • Authorization date:
  • 11-08-2008
  • Last update:
  • 21-02-2018